BioPorto A/S Price (BIOPOR.CO)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

358,498,000

(8.2416)%

BioPorto Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

BioPorto A/S, an in-vitro diagnostics company, provides biomarker tests and tools, and antibodies for clinicians and researchers in Europe, North America, Asia, and internationally. It offers the neutrophil gelatinase-associated lipocalin test, a quantitative particle-enhanced turbidimetric immunoassay designed to run on automated chemistry analyzers; monoclonal antibodies for scientific, pharmaceutical, and clinical research; and enzyme-linked immunosorbent assay kits, as well as generic rapid assay device for custom lateral flow assays. The company was... Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $1.21-2.85
  • Market Cap 616.13M
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Medical - Diagnostics & Research

  • ceo: Mr. Peter Moerch Eriksen B.B.A., BBA
  • IPO Date: January, 13, 2000
  • Country: DK
  • Currency: DKK
  • Headquaters: No Data
  • Employees: 36

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation